CASE STUDY #1

A researcher has approval from the IRB to conduct a drug study for which participants must have a certain level of kidney function. As a screening procedure, the researcher draws blood to assess kidney function. After the researcher has determined which individuals are eligible for the study, she explains the study to these individuals and invites them to participate, using her IRB-approved consent procedure.

Question: Did the researcher obtain appropriate consent from her participant?